Login / Signup

Predictive factors for survival outcomes of oligometastatic prostate cancer patients treated with metastases-directed therapy: a recursive partitioning-based analysis.

Ciro FranzeseLucia Di BrinaGiuseppe D'AgostinoDavide FranceschiniTiziana ComitoFiorenza De RoseAngelo TozziPierina NavarriaMarta Scorsetti
Published in: Journal of cancer research and clinical oncology (2019)
Oligometastatic PC represents nowadays a setting of particular interest in which local ablative therapies play a decisive role. In the present study, we recognized the importance of DFI, together with NCCN class risk, to predict the risk of new metastases after SBRT in oligometastatic PC.
Keyphrases
  • prostate cancer
  • radiation therapy
  • radical prostatectomy
  • stem cells
  • mesenchymal stem cells